News

Merck made the decision to discontinue development of MK-0354, an investigational niacin receptor, following completion of a phase II clinical trial that evaluated patients with dyslipidemia. Arena commented

<p>The agreement gives the companies the rights to produce and distribute generic versions of tenofovir disoproxil fumarate to 95 low-income countries around the world, including India. Tenofovir DF

Xyzal is a replacement of UCB’s previous allergy drug, Zyrtec which will lose its patent in the US in 2007. In July 2006, UCB submitted a new drug

Lamictal is an anti-seizure medication that will now be used to treat Primary Generalized Tonic-Clonic (PGTC) seizures as a result of the approval. With this new indication, Lamictal

The program has opened in the US and will open shortly in Canada and Europe, subject to the necessary approvals. The program will provide access for HIV-1 infected

“Patient satisfaction is a critical component to infertility treatment success,” said Stephen Somkuti, the lead author and coordinating investigator from Abington Reproductive Medicine. “By providing products that patients

The drugs will be developed to enhance the restorative benefits derived from sleep and offset problems associated with sleep deprivation. Under the award, Lexicon will be investigating the

Canada-based pharmaceutical firm Anormed agreed to sell Fosrenol to Shire in 2004 in return for milestone payments after the drug was approved in relevant countries. The recent $3

Statistical significance was achieved on all three criteria defined in the Special Protocol Assessment by the FDA. A significantly greater proportion of people taking Fampridine-SR had a consistent